Using orange fleshed sweet potato varieties to combat vitamin A deficiency and enhance market opportunities for smallholder farmers in sub-Saharan Africa.

Edward E. Carey, V. Hangenimana, L. K'Osambo, Oyunga, I. R. M. Benesi, N. E. J. M. Smit, C. Ocitti P'Obwoya, G. Turyamureeba, P. J. Ndolo, Jan W. Low

2000 · 14 citations · 6 references

Concepts

Abstract

Orange-fleshed sweetpotato varieties are rich in provitamin A and can contribute significantly to vitamin A nutrition in humans. Vitamin A deficiency is common many places in sub-Saharan Africa where sweetpotato is grown. However, most sweetpotato varieties currently grown here have either white or yellow flesh and are low in provitamin A. This paper briefly reviews recent experiences from Kenya and Uganda with respect to the identification and promotion of orange-fleshed varieties. Well-adapted orange-fleshed varieties are available and readily accepted by consumers, and can make a significant contribution to improving dietary vitamin A status, especially when provided in conjunction with information on the importance of vitamin A. As an additional incentive for their adoption, use of orange-fleshed sweetpotato as a wheat flour substitute in some snack food recipes, produces attractive and profitable products. Consideration is given to the varietal attributes and complementary information packages that will likely be required for orange-fleshed sweetpotatoes to significantly contribute to alleviating vitamin A deficiency and to increasing opportunities for income generation over wide areas of sub-Saharan Africa. Introduction. Vitamin A deficiency is a serious public health problem in many developing countries, including most of the countries of eastern, central and southern Africa (WHO, 1995). It mainly affects poor, young children (6 months to six years of age) and pregnant women. The clinical form of vitamin A deficiency, xerophthalmia, results when the eye is adversely affected, and is expressed as night blindness or, at its most severe, as total, irreversible blindness. Xerophthalmia affected an estimated 3.1 million children world-wide in 1995 (IVACG, 1995). Sub-clinical vitamin A deficiency affects many more people – an estimated 227.6 million in 1995 (IVACG, 1995) – and results in increased sickness and death rates due to diseases such as diarrhea and measles among those affected. There are two main causes of vitamin A deficiency in humans: failure to consume adequate amounts of vitamin A (or vitamin A precursors); and failure to absorb

References

6